ClinicalTrials.Veeva

Menu

Cancer Genome Analysis

Seoul National University logo

Seoul National University

Status

Unknown

Conditions

Malignant Tumor

Treatments

Other: next generation sequencing

Study type

Observational

Funder types

Other

Identifiers

NCT01458704
Cancer genome analysis

Details and patient eligibility

About

Next generation sequencing (including targeted gene seqeuncing, exome and transcriptome sequencing) will be performed from fresh frozen tumor samples to understand the genetic alteration of tumors and to aid in optimal selection of further therapeutic agents.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • patients with malignant tumor
  • receiving or planning to receive chemotherapy
  • with fresh frozen tumor tissue
  • with informed consent

Trial design

100 participants in 1 patient group

fresh frozen tumor tissue
Description:
patients providing fresh frozen tumor tissue
Treatment:
Other: next generation sequencing

Trial contacts and locations

1

Loading...

Central trial contact

Tae-You Kim

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems